XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]        
Product revenue $ 607,473 $ 893,548 $ 2,734,995 $ 2,385,701
Total revenue 607,473 893,548 2,734,995 2,385,701
Operating expenses        
Cost of sales 1,136,833 324,438 1,809,445 1,067,654
Research and development 114,141 279,049 (22,391) 774,526
Research and development - related party (Note 9) 291,963 387,960
Sales, general and administrative 4,637,495 4,385,145 13,809,264 13,732,226
Sales, general and administrative - related party (Note 9) 35,767 137,311
Impairment of intangible assets 1,856,020 1,856,020
Amortization of intangible assets 387,606 437,013 1,157,258 1,311,043
Total operating expenses 8,132,095 5,753,375 18,609,596 17,410,720
Loss from operations (7,524,622) (4,859,827) (15,874,601) (15,025,019)
Other (expense) income        
Interest (expense) (186,629) (80,722) (572,155) (884,187)
Derivative income 3,139,971 16,662 3,957,756 212,809
Unrealized gain on investment 230,936
(Loss) on investment (292,455) (292,455)
Other gain 1,753,568 1,753,568
Total other (expense) 4,706,910 (356,515) 5,139,169 (732,897)
Net loss $ (2,817,712) $ (5,216,342) $ (10,735,432) $ (15,757,916)
Weighted average number of common shares outstanding 11,855,413 546,931 5,009,545 378,118
Basic and diluted net loss per common share $ (0.24) $ (9.54) $ (2.14) $ (41.67)